Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miyuki Azuma

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patientsNaomi Takahashi, Kenji Matsumoto, Hirohisa Saito, et al.
Immunology|February 18, 2017
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacityMaja Wallberg, Asha Recino, Jenny Phillips, et al.
Immunology Letters|July 28, 2004
The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory rolePornpan Youngnak-Piboonratanakit, Fumihiko Tsushima, Noriko Otsuki, et al.
Blood|June 20, 2012
Process for immune defect and chromosomal translocation during early thymocyte development lacking ATMTakeshi Isoda, Masatoshi Takagi, Jinhua Piao, et al.
The Journal of Experimental Medicine|July 9, 2003
Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptorTahiro Shin, Gene Kennedy, Kevin Gorski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritisHideyuki Iwai, Masaaki Abe, Sachiko Hirose, et al.
Oral Oncology|March 31, 2019
Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockadeHidetake Tachinami, Naoto Nishii, Yulong Xia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2010
Roles for TGF-beta and programmed cell death 1 ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic miceOliver T Burton, Paola Zaccone, Jenny M Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
Receptor activator for NF-κB ligand in acute myeloid leukemia: expression, function, and modulation of NK cell immunosurveillanceBenjamin Joachim Schmiedel, Tina Nuebling, Julia Steinbacher, et al.
Oncotarget|March 24, 2018
Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapyNaoto Nishii, Hidetake Tachinami, Yuta Kondo, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2009
Impaired CD4 and CD8 effector function and decreased memory T cell populations in ICOS-deficient patientsNaomi Takahashi, Kenji Matsumoto, Hirohisa Saito, et al.
Immunology|February 18, 2017
Anti-CD3 treatment up-regulates programmed cell death protein-1 expression on activated effector T cells and severely impairs their inflammatory capacityMaja Wallberg, Asha Recino, Jenny Phillips, et al.
Immunology Letters|July 28, 2004
The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory rolePornpan Youngnak-Piboonratanakit, Fumihiko Tsushima, Noriko Otsuki, et al.
Blood|June 20, 2012
Process for immune defect and chromosomal translocation during early thymocyte development lacking ATMTakeshi Isoda, Masatoshi Takagi, Jinhua Piao, et al.
The Journal of Experimental Medicine|July 9, 2003
Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptorTahiro Shin, Gene Kennedy, Kevin Gorski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritisHideyuki Iwai, Masaaki Abe, Sachiko Hirose, et al.
Oral Oncology|March 31, 2019
Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockadeHidetake Tachinami, Naoto Nishii, Yulong Xia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 3, 2010
Roles for TGF-beta and programmed cell death 1 ligand 1 in regulatory T cell expansion and diabetes suppression by zymosan in nonobese diabetic miceOliver T Burton, Paola Zaccone, Jenny M Phillips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 18, 2012
Receptor activator for NF-κB ligand in acute myeloid leukemia: expression, function, and modulation of NK cell immunosurveillanceBenjamin Joachim Schmiedel, Tina Nuebling, Julia Steinbacher, et al.
Oncotarget|March 24, 2018
Systemic administration of a TLR7 agonist attenuates regulatory T cells by dendritic cell modification and overcomes resistance to PD-L1 blockade therapyNaoto Nishii, Hidetake Tachinami, Yuta Kondo, et al.
Pageof 16